Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2014
09/18/2014WO2014139539A1 Inhibitor of dpysl3/crmp4 for treatment of bone loss
09/18/2014WO2014139512A1 Derivatives of indoles and carbazoles, method for the production thereof and use thereof as mrsa-sensitive antibiotics
09/18/2014WO2014139476A1 Epitope of rsv fusion protein and antibody identifying same
09/18/2014WO2014139469A1 Ornithine- or aspartate-containing compositions and the uses thereof
09/18/2014WO2014139465A1 Novel pyrimidine and pyridine compounds and their usage
09/18/2014WO2014139458A1 Fused ring compound containing pyrimidine or pyridine and use thereof as anti-tumour drug
09/18/2014WO2014139447A1 Crystal form a of (1s)-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-1,6-dideoxy-d-glucose and preparation method and use thereof
09/18/2014WO2014139391A1 Substituted pyridine compounds as kinases inhibitors
09/18/2014WO2014139388A1 Novel indole derivatives useful as anti-diabetic agents
09/18/2014WO2014139328A1 Pyrrolo[2,3-b]pyridine cdk9 kinase inhibitors
09/18/2014WO2014139326A1 Pyrazolo compounds and uses thereof
09/18/2014WO2014139325A1 Therapeutic compounds and compositions
09/18/2014WO2014139324A1 Tetracyclic bromodomain inhibitors
09/18/2014WO2014139318A1 Application of phthalide compound
09/18/2014WO2014139227A1 Lump sugar, and production method and application thereof
09/18/2014WO2014139161A1 Novel high penetration drugs and their compositions thereof for treatment of parkinson diseases
09/18/2014WO2014139150A1 Substituted pyridizinone derivatives as pde10 inhibitors
09/18/2014WO2014139145A1 Novel pyrimidine and pyridine compounds and usage thereof
09/18/2014WO2014139144A1 Therapeutic compounds and compositions
09/18/2014WO2014139033A1 Compounds and compositions for drug release
09/18/2014WO2014139014A1 Methods and compositions for the inhibition of vascular endothelial growth factor activity and vascular permeability
09/18/2014WO2014138987A1 Use of electroretinography (erg) for the assessment of psychiatric disorders
09/18/2014WO2014138979A1 Pyrazole derivatives and their uses thereof
09/18/2014WO2014138975A1 Preparation and method for use in the treatment of respiratory diseases
09/18/2014WO2014138922A1 Uses for idebenone and related benzoouinones in ppar-related diseases and conditions
09/18/2014WO2014138920A1 Method for extracting organic solids and oil from marine organisms enriched with astaxanthin
09/18/2014WO2014138912A1 Luminescent compounds and methods of using same
09/18/2014WO2014138907A1 Substituted aromatic compounds for the treatment of pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis
09/18/2014WO2014138906A1 Substituted aromatic compounds and related method for the treatment of fibrosis
09/18/2014WO2014138905A1 Forms of sorafenib tosylate and processes for the preparation thereof
09/18/2014WO2014138897A1 Hyaluronic acid derivatives
09/18/2014WO2014138881A1 Drug delivery system
09/18/2014WO2014138833A1 Compounds, use, pharmaceutical composition for inhibiting reductase in microorganisms, inha binder and method for obtaining inha binders
09/18/2014WO2014138824A1 Immune modulation
09/18/2014WO2014138823A1 Compounds and uses thereof in the treatment/prevention of gram-negative bacterial infections
09/18/2014WO2014138821A1 Improved air purifying apparatus, method & use of chemical substance
09/18/2014WO2014138814A1 S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis
09/18/2014WO2014138812A1 Salts, co-crystals, and polymorphs of an anxiolytic compound
09/18/2014WO2014138806A1 Oxprenolol compositions for treating cancer
09/18/2014WO2014138802A1 Canrenoate compositions for treating cancer
09/18/2014WO2014138791A1 Transgenic non-human organisms with non-functional tspo genes
09/18/2014WO2014138772A1 A crystalline form of an anxiolytic compound
09/18/2014WO2013164337A9 Pyrimidine derivatives for the treatment of bacterial diseases
09/18/2014WO2013100571A9 Phenyl carbamate compounds for use in preventing or treating als
09/18/2014WO2013091089A9 Three-dimensional cavities of dendritic cell immunoreceptor (dcir), compounds binding thereto and therapeutic applications related to inhibition of human immunodeficiency virus type-1 (hiv-1)
09/18/2014US20140276483 Transdermal methylphenidate compositions with acrylic block copolymers
09/18/2014US20140276482 Systems for Sustained Intraocular Delivery of Low Solubility Compounds from a Port Delivery System Implant
09/18/2014US20140276480 Biomolecular wearable apparatus
09/18/2014US20140276479 Transdermal drug delivery system with overlay
09/18/2014US20140276478 Compositions and methods for transdermal delivery of tertiary amine drugs
09/18/2014US20140276477 Method of treating infections, diseases or disorders of nail unit
09/18/2014US20140276363 Sonochemical Induction of ABCA1 Expression and Compositions Therefor
09/18/2014US20140276361 Systems and methods for treating glaucoma
09/18/2014US20140276355 Co-administration of Light and a Therapeutic Agent to Stimulate Dysfunctional Mitochondria Affected By a Neurological Disorder
09/18/2014US20140276312 Combinatorial therapy for treatment of osteoarthritis of the knee
09/18/2014US20140275711 1-(Arylmethyl)-5,6,7,8-tetrahydroquinazolline-2,4-diones and Analogs and the Use Thereof
09/18/2014US20140275618 Therapeutic compounds and methods of use
09/18/2014US20140275610 Process for the preparation of fesoterodine or a salt thereof
09/18/2014US20140275545 8-carboxamido-2,6-methano-3-benzazocines
09/18/2014US20140275509 Multifunctionalized materials
09/18/2014US20140275479 Specific binding agents of human angiopoeitin-2
09/18/2014US20140275469 Amine functional polyamides
09/18/2014US20140275285 Metadichol® liquid and gel nanoparticle formulations
09/18/2014US20140275283 Product and Method for Improving Bioavailability of Therapeutic Compounds
09/18/2014US20140275282 Treating osteopenia and related disorders with geranylgeranyl acetone and derivatives thereof
09/18/2014US20140275281 Geranylgeranyl acetone and derivatives thereof for intranasal administration
09/18/2014US20140275280 Therapeutic uses of geranylgeranyl acetone and derivatives thereof
09/18/2014US20140275279 Cysteamine in the treatment of fibrotic disease
09/18/2014US20140275278 Pharmaceutical composition of s-ketamine hydrochloride
09/18/2014US20140275277 Pharmaceutical composition of s-ketamine hydrochloride
09/18/2014US20140275276 Pharmaceutical composition of s-ketamine hydrochloride
09/18/2014US20140275275 Chlorhexadine Antiseptic
09/18/2014US20140275274 Synergistic ophthalmic compositions for disinfecting contact lenses
09/18/2014US20140275272 Prostamides for enhancement of leptin production
09/18/2014US20140275270 Isolated Stereoisomeric Forms Of (S)2-N(3-O-(Propan 2-Ol)-1-Propyl-4-Hydroxybenzene)-3-Phenylpropylamide
09/18/2014US20140275266 Prostanoid receptor agonist compounds and methods of use for same
09/18/2014US20140275265 Therapeutic cream for application to skin
09/18/2014US20140275264 Synergistic combinations of organic acid useful for controlling microoganisms in industrial processes
09/18/2014US20140275263 Microemulsion Topical Delivery Platform
09/18/2014US20140275261 Diclofenac parenteral compositions
09/18/2014US20140275260 Preparation Of Stable Pharmaceutical Dosage Forms
09/18/2014US20140275259 Direct Lipid to Membrane Drug Delivery
09/18/2014US20140275258 Chelation Suppository for Improved Drug Delivery
09/18/2014US20140275257 N-acetyl cysteine compositions in the treatment of systemic lupus erythematosus
09/18/2014US20140275256 Transepithelial Methods Of Using Gamma Aminobutyric Acid Compositions For Pain Relief
09/18/2014US20140275255 Antiviral compositions and methods for inactivating non-enveloped viruses using alkyl 2-hydroxycarboxylic acids
09/18/2014US20140275254 Pharmaceutical composition for the treatment of fungal infections
09/18/2014US20140275253 Compositions and methods for treating or preventing obesity in a subject in need thereof
09/18/2014US20140275252 Methods of treating traumatic brain injury
09/18/2014US20140275251 Composition for external use on skin for inflammatory diseases
09/18/2014US20140275250 Methods of Administering Monomethyl Fumarate
09/18/2014US20140275249 Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container
09/18/2014US20140275248 Treatment of molluscum contagiosum
09/18/2014US20140275246 Racecadotril lipid compositions
09/18/2014US20140275245 Bicyclic analgesic compounds
09/18/2014US20140275242 Hot melt granulation formulations of poorly water-soluble active agents
09/18/2014US20140275240 Suppression and prevention of tumors and treatment of viruses
09/18/2014US20140275239 Dronedarone Formulation
09/18/2014US20140275237 Beraprost isomer as an agent for the treatment of viral infection
09/18/2014US20140275236 Novel anti-neurodegenerative natural compounds isolated from Alpiniae Oxyphyllae Fructus and their total synthesis
1 ... 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 ... 7860